NCT05749354: GJZLBQGNZA

Clinical Efficacy of Acupuncture on the Liver Meridian in Men With Erectile Dysfunction Reserve

Status unknown NA Last updated 1 March 2023

What this trial tests

NA trial testing electroacupuncture in Erectile Dysfunction in 159 participants. Status unknown.

Timeline

11 January 2023

Primary endpoint
11 December 2023

31 December 2023

Quick facts

Lead sponsor	The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	159
Start date	11 January 2023
Primary completion	11 December 2023
Estimated completion	31 December 2023
Sites	1 location across China

Drugs / interventions tested

• electroacupuncture

Conditions studied

• Erectile Dysfunction — all drugs for Erectile Dysfunction →
• Acupuncture Therapy — all drugs for Acupuncture Therapy →
• Median Nerve Disease — all drugs for Median Nerve Disease →

Sponsor

The First Affiliated Hospital of Hunan University of Traditional Chinese Medicine

Who can join

Adults 22 to 50, male only, with Erectile Dysfunction or Acupuncture Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Erectile dysfunction (ED) is a kind of worldwide and common sexual dysfunction disease, which mainly affects men over forty years old. The clinical characteristics of ED is the inability to maintain sufficient erection to obtain satisfactory sexual intercourse. Age, education, diabetes, stroke, obesity, and hypertension are factors inducing ED. Recent years, the prevalence of ED is rising, and more men aged below forty years old are suffering ED. Published review indicated that the prevalence of ED was 40.56% in Chinese men aged over forty years old. A survey conducted in China suggested that 40.56% men aged over forty years old suffered from ED. Another international survey found that, 21.48% sexually active participants suffered from ED. Several researches demonstrated that, ED affects health and quality of life of patients and partner. Besides, ED induces patients' psychosocial problems, including depression and anxiety, and reduce work efficiency. According to American Urological Association guideline published in 2018, the clinical therapies for ED include phosphodiesterase type 5 inhibitor (PDE5i), vacuum erection device, and penile prosthesis implantation. PDE5i (such as sildenafil, vardenafil, and tadalafil) is a first-line drug for ED, recommended by doctors and patients. However, the most common side effects of PDE5i were headache, dyspepsia, flushing, and blurred vision. Furthermore, the ideal dose and type of PDE5i still need to be further studied. The use of PDE5i is restricted by those reasons.

Acupuncture is an important role of Traditional Chinese Medicine (TCM), and acupuncture received more concerned recently. The correlation between meridians and viscera is the center of acupuncture scientific problem. Acupoints stimulation can regulate visceral sensation and mobility to treat diseases.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.